Insider · CIK 0001209588
Don M Hardison
Files at CTKB (Cytek Biosciences, Inc.), MDXH (MDxHealth SA). First filing -, latest -.
In brief
Don M Hardison files SEC Form 4 as director at CTKB (Cytek Biosciences, Inc.), and also at MDXH (MDxHealth SA). No open-market trade is on file; the transactions below are grants, exercises and other rows that carry no view on the price.
A track record needs three past buys with six months of prices behind them; Don M Hardison has 0, so none is measured yet.
Signals
This insider’s open-market buys and sells, scored.
Transactions
Every row this insider has filed, 5 in all, newest first.
| Date | Company | Transaction | Shares | Price | Value | Holdings after | Filed |
|---|---|---|---|---|---|---|---|
| Jun 1, 2026 | MDXH MDxHealth SA | AGrant or award Share Optionderivative | +10,000 | $0.00 | $0 | 10,000 | Jun 3, 2026 |
| Jun 5, 2025 | CTKB Cytek Biosciences, Inc. | MOption exercise Common Stock | +15,706 | - | - | 15,706 | Jun 9, 2025 |
| Jun 5, 2025 | CTKB Cytek Biosciences, Inc. | MOption exercise Restricted Stock Unitsderivative | -15,706 | $0.00 | $0 | 0 | Jun 9, 2025 |
| Jun 5, 2024 | CTKB Cytek Biosciences, Inc. | AGrant or award Restricted Stock Unitsderivative | +15,706 | $0.00 | $0 | 15,706 | Jun 7, 2024 |
| Jun 5, 2024 | CTKB Cytek Biosciences, Inc. | AGrant or award Stock Option (right to buy)derivative | +23,076 | $0.00 | $0 | 23,076 | Jun 7, 2024 |
Questions about Don M Hardison
Answered from the filings on this page, as of the latest one.
Is Don M Hardison buying or selling?
Don M Hardison has no open-market buy or sell on SEC Form 4; the filings on record are grants, exercises and other transactions.
How did Don M Hardison's past buys perform?
Not measured yet. InsiderTell needs three past buys with six months of prices to publish a track record, and Don M Hardison has 0.
Where does Don M Hardison file Form 4?
Don M Hardison has filed Form 4 at CTKB (Cytek Biosciences, Inc.); MDXH (MDxHealth SA). A Form 4 is required of officers, directors and holders of more than 10% of a share class within two business days of a trade.
Not investment advice. Scores and forward returns are decision support built from public SEC filings and past prices; they describe what happened after comparable filings, not what will happen after this one. Do your own research and size your risk.